REGULATED PRESS RELEASE published on 03/07/2025 at 18:00, 1 year 8 months ago AXA: Information relating to the number of voting rights and shares making up the share capital on 28/02/2025 AXA, a public company under French law, discloses information on voting rights and share capital. Details include total shares and voting rights as of February 28, 2025 Share Capital Voting Rights AXA Disclosure French Law
REGULATED PRESS RELEASE published on 03/07/2025 at 18:00, 1 year 8 months ago AXA : Information relative au nombre total de droits de vote et d'actions composant le capital social au 28/02/2025 AXA divulgue les informations sur son capital social et les droits de vote conformément à la réglementation financière en vigueur Droits De Vote Capital Social AXA Réglementation Informations Financières
BRIEF published on 02/28/2025 at 18:56, 1 year 8 months ago AXA Executes Share Repurchase Agreement Share Repurchase Investment Strategy AXA Buy-back Program Capital Management
BRIEF published on 02/28/2025 at 18:56, 1 year 8 months ago AXA signe une convention pour racheter ses actions jusqu'à 1,2 milliard d'euros Investissement Rachat D'actions BNP Paribas AXA Gestion Du Capital
REGULATED PRESS RELEASE published on 02/28/2025 at 18:51, 1 year 8 months ago AXA - Execution of a share repurchase agreement in relation to AXAs share buy-back program of up to Euro 1.2 billion AXA executes share repurchase agreement of up to Euro 1.2 billion as part of its capital management policy, buying back shares from March 3 to June 30, 2025 Share Repurchase AXA Purchase Period Euro 1.2 Billion Capital Management Policy
REGULATED PRESS RELEASE published on 02/28/2025 at 18:51, 1 year 8 months ago AXA - Conclusion d’une convention de rachat d’actions dans le cadre du programme de rachat d’actions d’AXA d’un montant maximal de 1,2 milliard d'euros AXA conclut une convention de rachat d'actions d'un montant maximal de 1,2 milliard d'euros pour annulation. Les rachats s'effectueront du 3 mars au 30 juin 2025, avec un prix basé sur le cours moyen de l'action Rachat D'actions AXA Annulation Milliard D'euros Cours Moyen
REGULATED PRESS RELEASE published on 02/27/2025 at 07:00, 1 year 8 months ago AXA - Résultats annuels 2024
REGULATED PRESS RELEASE published on 02/27/2025 at 07:00, 1 year 8 months ago AXA - Full Year 2024 Earnings
BRIEF published on 02/14/2025 at 18:05, 1 year 8 months ago AXA : Détails des droits de vote et actions au 31 janvier 2025 Droits De Vote Franchissement De Seuil Capital Social Actions AXA
BRIEF published on 02/14/2025 at 18:05, 1 year 8 months ago AXA Updates on Voting Rights and Share Capital Structure Share Capital Voting Rights French Commercial Code Disclosure Requirements AXA Bylaws
Published on 11/06/2026 at 22:15, 2 days 10 hours ago Jaguar Health Reports Approval of All Proposals at November 2026 Special Meeting of Stockholders
Published on 11/06/2026 at 13:00, 2 days 20 hours ago Alaska Energy Metals Achieves High Extraction Rates of Metals from Hydromet Testing, Nikolai Nickel Project, Alaska
Published on 11/06/2026 at 12:30, 2 days 20 hours ago Relevant Gold Receives Expanded Drilling Approvals for the Lewiston Project in Wyoming
Published on 11/06/2026 at 12:30, 2 days 20 hours ago Vogenx Reports Third Quarter 2026 Financial Results and Business Highlights
Published on 11/09/2026 at 08:15, 54 minutes ago EQS-Adhoc: Airbus SE: Airbus commences multi-year share buyback programme, with launch of the first tranche
Published on 11/09/2026 at 08:05, 1 hour 3 minutes ago Onodrim Industries secures $300 million Series A at $1.3 billion valuation to strengthen Europe's defence and industrial foundations
Published on 11/09/2026 at 08:00, 1 hour 9 minutes ago Aquis Stock Exchange: Transfer to Apex segment
Published on 11/09/2026 at 07:00, 2 hours 9 minutes ago bioMérieux receives U.S. FDA 510(k) clearance for the latest versions of the BIOFIRE® FILMARRAY® Gastrointestinal Panels to enhance detection of gastrointestinal pathogens including norovirus
Published on 11/09/2026 at 07:00, 2 hours 9 minutes ago BIOPHYTIS ANNOUNCES THE OPERATIONAL LAUNCH OF ITS JOINT VENTURE IN CHINA
Published on 11/09/2026 at 07:00, 2 hours 9 minutes ago Biophytis annonce le démarrage opérationnel de sa co-entreprise en Chine
Published on 11/09/2026 at 07:00, 2 hours 9 minutes ago bioMérieux obtient l’autorisation 510(k) de la FDA américaine pour les dernières versions des tests BIOFIRE® FILMARRAY® Gastrointestinal Panels afin d’optimiser la détection des pathogènes gastrointestinaux, dont le norovirus
Published on 11/06/2026 at 19:06, 2 days 14 hours ago ALTAREIT : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES OCTOBRE 2026